Login to Your Account



Financings Roundup

RedX Pharma Raising $17M for Antiviral, Antibody Work

By Nuala Moran
Staff Writer

Monday, July 16, 2012

LONDON – RedX Pharma Ltd. is planning a £10.8 million (US$16.8 million) investment to extend the reach of its expertise in the structural modification of marketed drugs into antibiotics and antivirals.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription